Referenced in: none

Automatically associated channels: Kv11.1

Title: Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients.

Authors: Neeraj Gupta, Yeamin Huh, Matthew M Hutmacher, Sean Ottinger, Ai-Min Hui, Karthik Venkatakrishnan

Journal, date & volume: Cancer Chemother. Pharmacol., 2015 Sep , 76, 507-16

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/26141494

Abstract